Dr. Miltons Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 15-11-2024
- Paid Up Capital ₹ 5.24 Cr
as on 15-11-2024
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.73 Cr
as on 15-11-2024
- Satisfied Charges ₹ 15.21 Cr
as on 15-11-2024
- Revenue -19.40%
(FY 2023)
- Profit 19.83%
(FY 2023)
- Ebitda 13.34%
(FY 2023)
- Net Worth 2.34%
(FY 2023)
- Total Assets 2.03%
(FY 2023)
About Dr. Miltons Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 5.24 Cr.
The company currently has active open charges totaling ₹13.73 Cr. The company has closed loans amounting to ₹15.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nagarajan Pramodh and Thulasi Brinda serve as directors at the Company.
- CIN/LLPIN
U24230TN2007PTC065403
- Company No.
065403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr. Miltons Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagarajan Pramodh  | Director | 14-Sep-2016 | Current |
| Thulasi Brinda | Director | 14-Sep-2016 | Current |
Financial Performance of Dr. Miltons Laboratories.
Dr. Miltons Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.4% decrease. The company also saw a substantial improvement in profitability, with a 19.83% increase in profit. The company's net worth moved up by a moderate rise of 2.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Miltons Laboratories?
In 2023, Dr. Miltons Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Psibertech Solutions Private LimitedActive 11 years 7 monthsNagarajan Pramodh and Thulasi Brinda are mutual person
Superbiz Businesses India Private LimitedActive 11 years 3 monthsNagarajan Pramodh and Thulasi Brinda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jun 2024 | ₹4.15 M | Open |
Axis Bank Limited Creation Date: 03 Mar 2018 | ₹13.31 Cr | Open |
Others Creation Date: 21 Nov 2016 | ₹3.20 Cr | Satisfied |
How Many Employees Work at Dr. Miltons Laboratories?
Dr. Miltons Laboratories has a workforce of 130 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Miltons Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Miltons Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
